Real-time cancer monitoring via leukocyte adhesion in a biomimetic microfluidic assay
Biosensors and Bioelectronics · 2026
DOI: 10.1016/j.bios.2025.118311 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2026. Verfasst von Brian Choi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, College of Information and Biotechnology, Ulsan National Institute of Science and Technology (UNIST), UNIST gil…. Hauptthemen laut MEDLINE: Leukocytes, Microfluidic Analytical Techniques, Biosensing Techniques. Die Arbeit nennt 52 Literaturangaben. Gefördert von: Korea Ministry of Trade Industry and Energy, Korea Ministry of Health and Welfare, Korea Ministry of Science and ICT.
Abstract (Originalsprache)
Cancer progression involves cell adhesion molecules (CAMs), which facilitate the recruitment of leukocytes and metastatic tumor cells to distant organs by mediating adhesion with endothelial cells. While CAM-mediated tumor dissemination is well studied, the diagnostic potential of CAM ligand-expressing activated leukocytes as biomarkers reflecting the host's inflammatory response to cancer remains relatively unexplored. This study presents a microfluidic device that assesses cancer-driven leukocyte activation in a 4T1 breast cancer mouse model by quantifying leukocyte adhesion to CAM-coated microchannels under physiological flow conditions. In a 4T1 mouse model, inflammation induces upregulation of CAM ligands that enhance selectin-mediated adhesion between leukocytes and endothelial cells. The proportion of leukocytes expressing CAM ligands correlates with cancer progression, accompanied by an approximately 40-fold enhancement in leukocyte adhesion within a vascular endothelium-mimicking microchannel coated with CAMs following implantation of 4T1 cells in mice. Quantification of leukocyte adhesion in this system discriminates experimental conditions corresponding to primary tumor growth, chemotherapeutic response, and postsurgical recurrence or metastasis in the 4T1 mouse model. These findings establish leukocyte adhesion profiling in a biomimetic microfluidic assay as a functional biomarker of cancer-driven inflammation in vivo and support its potential as a complementary tool for translational cancer monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, College of Information and Biotechnology, Ulsan National Institute of Science and Technology (UNIST), UNIST gil 50, Ulsan, 44919, Republic of Korea.
- Department of Biomedical Engineering, College of Information and Biotechnology, Ulsan National Institute of Science and Technology (UNIST), UNIST gil 50, Ulsan, 44919, Republic of Korea. Electronic address: jookang@unis…
Förderung
- Korea Ministry of Trade Industry and Energy
- Korea Ministry of Health and Welfare
- Korea Ministry of Science and ICT
- National Research Foundation of Korea
- Ulsan National Institute of Science and Technology
Zitieren
APA
Choi, B., Kwon, S., Lee, M. S., Kurmashev, A., & Kang, J. H. (2026). Real-time cancer monitoring via leukocyte adhesion in a biomimetic microfluidic assay. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2025.118311
Vancouver
Choi B, Kwon S, Lee MS, Kurmashev A, Kang JH. Real-time cancer monitoring via leukocyte adhesion in a biomimetic microfluidic assay. Biosensors and Bioelectronics. 2026. doi:10.1016/j.bios.2025.118311
BibTeX
@article{Choi2026,
author = {Choi, Brian and Kwon, Seyong and Lee, Min Seok and Kurmashev, Amanzhol and Kang, Joo H},
title = {Real-time cancer monitoring via leukocyte adhesion in a biomimetic microfluidic assay},
journal = {Biosensors and Bioelectronics},
year = {2026},
doi = {10.1016/j.bios.2025.118311}
}
EUVIMED